MME GIOVANNA LOLLO

Pharmaceutical engineering, Nanomedicine, Nanotechnology, Pharmacology

Dr. Lollo's research is centered on translational projects aimed at creating innovative nanomedicines to address complex medical needs. Her work employs a multidisciplinary approach for the development and physico-chemical characterization of drug delivery nanosystems. The challenge is to overcome biological barriers and to reach the target while minimizing side effects. The efficacy of this strategy has been demonstrated in different therapeutic areas as auto-immune diseases, oncology and more recently muscular diseases.

LinkedIn: https://www.linkedin.com/in/giovannalollo
ResearchGate: https://www.researchgate.net/profile/Giovanna-Lollo

2024 Junior Member of the Institut Universitaire de France
2021 Habilitation à diriger des recherches (HDR), University Lyon 1, France.
Dissertation: Overcoming biological barriers using nanomedicines for the treatment of immune related diseases
2009 – 2012 Ph.D. in Pharmaceutical Development and Research, University of Santiago de Compostela, Spain.
Thesis: Polyaminoacid nanocapsules as drug delivery systems for antitumor drugs. Cum Laude
2007 – 2009 Master of Sciences – Pharmaceutical Technology, University of Santiago de Compostela, Spain.
Thesis: New oral drug delivery systems for anticancer drugs
2008 – 2010 Specialization in Hospital Pharmacy, University of Naples Federico II, Italy.
Thesis: Photodynamic therapy: new nanometric systems for the delivery of photoactive substances in cancer therapy.
2002 – 2007 Bachelor degree in Pharmacy, University of Naples Federico II, Italy.
Thesis: Nanometric Systems for Drug Delivery. Cum Laude

Maitre de conférences